Search results
Showing: 10 of 1380
Summary of NHSBSA Board minutes - 16 October 2025
Meeting held at 9:00am in Stella House, Newcastle Upon Tyne. Present: Sue Douthwaite, ChairMichael Brodie, Chief ExecutiveKathy Gillatt, Non-Executive DirectorDavid Leather, Non-Executive DirectorMathew McKie, Non-Executive DirectorRandeep…
Pharmacy First June 2025
This is a news article on behalf of the Department of Health and Social Care
The clinical protocols and patient group directions (PGDs) for the NHS Pharmacy First service were updated in June 2025 to include some changes to the…
Prescription Cost Analysis - England 2019
Correction notice - a column was omitted from the presentation level tables of the latest release
Read our correction notices page for full details. Go to our Office for Statistics Regulation Assessment page to view their assessment of…
Requesting our dental data
If you require access to a specific set of dental data this can be requested in different ways. This page details the options available and provides more information on the process involved in each.Academic Research requests (patient…
Estimates report
Key findingsThe comparison of expected uptake to the actual volume of medicines used in the NHS in England is available in the national level medicine groupings interactive dashboard.The expected uptake is shown where it has been possible to…
Rivaroxaban addition to Category A and M from September 2024
The addition of the following products into Category A:
Rivaroxaban 2.5mg tablets
Rivaroxaban 10mg tablets
The addition of the following products into Category M:
Rivaroxaban 15mg tablets
Rivaroxaban 20mg tablets
These additions are…
Drug Reimbursement – Azathioprine 50mg/5ml oral suspension
Since February 2024, a licensed version of Azathioprine 50mg/5ml oral suspension became available. Therefore, for prescriptions dispensed in February and March 2024:
where there is an endorsement for the licensed product, then reimbursement will…
Prescribing comparators
Access for:registered users via ePACT2public users via CatalystThe report shows potential savings that may be achieved by prescribing generically. The specialist drugs report is produced at national, ICB, commissioner / provider and…
Repeat dispensing report (including EPS items)
Access for:registered users via ePACT2public users via CatalystRepeat dispensing reports are a set of reports which provide information at both cost and item level.Report notesThere are 3 data views available, which are:…
Policies and procedures
This page was last reviewed and updated 11 May 2021The official statistics we publish follow the UK Statistics Authority’s Code of Practice for Statistics.The documents on this page describe the standards we follow to produce official…